WO2004029089A3 - Nouvelle cible de l’ angiogenese et utilisations - Google Patents
Nouvelle cible de l’ angiogenese et utilisations Download PDFInfo
- Publication number
- WO2004029089A3 WO2004029089A3 PCT/FR2003/002810 FR0302810W WO2004029089A3 WO 2004029089 A3 WO2004029089 A3 WO 2004029089A3 FR 0302810 W FR0302810 W FR 0302810W WO 2004029089 A3 WO2004029089 A3 WO 2004029089A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- relates
- diagnostic
- angiogenesis
- therapeutic
- field
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Heart & Thoracic Surgery (AREA)
- Toxicology (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Physical Education & Sports Medicine (AREA)
- Dermatology (AREA)
- Cell Biology (AREA)
- Cardiology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Peptides Or Proteins (AREA)
Abstract
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU2003299096A AU2003299096A1 (en) | 2002-09-25 | 2003-09-24 | Novel angiogenesis target and uses thereof |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0211853A FR2844713A1 (fr) | 2002-09-25 | 2002-09-25 | Nouvelle cible de l'angiogenese et utilisations |
FR02/11853 | 2002-09-25 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2004029089A2 WO2004029089A2 (fr) | 2004-04-08 |
WO2004029089A3 true WO2004029089A3 (fr) | 2004-06-17 |
Family
ID=31970980
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/FR2003/002810 WO2004029089A2 (fr) | 2002-09-25 | 2003-09-24 | Nouvelle cible de l’ angiogenese et utilisations |
Country Status (3)
Country | Link |
---|---|
AU (1) | AU2003299096A1 (fr) |
FR (1) | FR2844713A1 (fr) |
WO (1) | WO2004029089A2 (fr) |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1999046403A1 (fr) * | 1998-03-11 | 1999-09-16 | Exonhit Therapeutics S.A. | Criblage differentiel qualitatif |
WO2001029221A2 (fr) * | 1999-10-20 | 2001-04-26 | Zymogenetics, Inc. | Nouvelles proteines et polynucleotides codant ces proteines |
WO2001090304A2 (fr) * | 2000-05-19 | 2001-11-29 | Human Genome Sciences, Inc. | Acides nucleiques, proteines et anticorps |
WO2002014499A2 (fr) * | 2000-08-15 | 2002-02-21 | Immunex Corporation | Polypeptides de claudines |
WO2002024888A2 (fr) * | 2000-09-01 | 2002-03-28 | Genentech, Inc. | Polypeptides secretes transmembranaires et acides nucleiques codant pour ceux-ci |
WO2002070539A2 (fr) * | 2001-03-05 | 2002-09-12 | Hyseq, Inc. | Nouveaux acides nucleiques et polypeptides |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2002099083A2 (fr) * | 2001-06-05 | 2002-12-12 | Exelixis, Inc. | Gfat en tant que modificateurs de la voie p53 et leur procede d'utilisation |
-
2002
- 2002-09-25 FR FR0211853A patent/FR2844713A1/fr not_active Withdrawn
-
2003
- 2003-09-24 WO PCT/FR2003/002810 patent/WO2004029089A2/fr not_active Application Discontinuation
- 2003-09-24 AU AU2003299096A patent/AU2003299096A1/en not_active Abandoned
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1999046403A1 (fr) * | 1998-03-11 | 1999-09-16 | Exonhit Therapeutics S.A. | Criblage differentiel qualitatif |
WO2001029221A2 (fr) * | 1999-10-20 | 2001-04-26 | Zymogenetics, Inc. | Nouvelles proteines et polynucleotides codant ces proteines |
WO2001090304A2 (fr) * | 2000-05-19 | 2001-11-29 | Human Genome Sciences, Inc. | Acides nucleiques, proteines et anticorps |
WO2002014499A2 (fr) * | 2000-08-15 | 2002-02-21 | Immunex Corporation | Polypeptides de claudines |
WO2002024888A2 (fr) * | 2000-09-01 | 2002-03-28 | Genentech, Inc. | Polypeptides secretes transmembranaires et acides nucleiques codant pour ceux-ci |
WO2002070539A2 (fr) * | 2001-03-05 | 2002-09-12 | Hyseq, Inc. | Nouveaux acides nucleiques et polypeptides |
Non-Patent Citations (4)
Title |
---|
DATABASE EM_HUM EMBL; 29 September 2000 (2000-09-29), XP002250864, Database accession no. AK024551 * |
DATABASE GSN GENESEQ; 20 January 2003 (2003-01-20), XP002250865, Database accession no. ABZ11501 * |
DATABASE GSP [online] GENESEQ; 24 May 2002 (2002-05-24), XP002272083, Database accession no. ABB90003 * |
DATABASE GSP GENESEQ; 20 January 2003 (2003-01-20), XP002250866, Database accession no. ABP69284 * |
Also Published As
Publication number | Publication date |
---|---|
FR2844713A1 (fr) | 2004-03-26 |
AU2003299096A8 (en) | 2004-04-19 |
WO2004029089A2 (fr) | 2004-04-08 |
AU2003299096A1 (en) | 2004-04-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2004047728A3 (fr) | Compositions et procedes destines au traitement de maladies de nature immune | |
WO2008077945A3 (fr) | Séquences d'acides aminés dirigées contre des chimiokines et polypeptides comprenant celles-ci pour le traitement de maladies et de troubles liés aux chimiokines | |
EP2182006A3 (fr) | Compositions et procédés pour le traitement de maladies liées au système immunitaire | |
WO2004009622A3 (fr) | Complexes de proteiniques de reseaux cellulaires fondant le developpement du cancer et d'autres maladies | |
WO2005014035A3 (fr) | Utilisation de galactose oxydase pour la conjugaison chimique selective de molecules d'extraction a des proteines d'interet therapeutique | |
EP2322203A3 (fr) | Les compositions et les methodes pour le traitement de maladies liees immunisees | |
WO2001068708A3 (fr) | ANTICORPS HUMAINS SPECIFIQUES DE FAP-$g(a) | |
DE69922261D1 (de) | Monoklonale antikörper, antigene sowie diagnose und therapie von bösartigen krankheiten | |
WO2004029093A3 (fr) | Anticorps anti-granulocytes chimeres, humains et humainises | |
EP2093298A3 (fr) | Compositions pour le diagnostic et la thérapie des maladies associées à l'expression aberrante de futrines (R-Spondins) | |
WO2002050277A3 (fr) | Proteines et acides nucleiques codant pour celles-ci | |
WO2021181233A3 (fr) | Protéines de fusion et leurs utilisations | |
WO2001064877A3 (fr) | Gene humain de la schizophrenie | |
TW200734638A (en) | Method for the diagnosis of thromboembolic and coronary heart diseases | |
EP2083018A3 (fr) | Compositions et procédés associés à STOP-1 | |
WO2005000335A3 (fr) | Procedes de diagnostic et de traitement lies au vieillissement, en particulier au vieillissement du foie | |
WO2004024072A3 (fr) | Nouvelles compositions et methodes pour le traitement de maladies associees au systeme immunitaire | |
WO2004015060A3 (fr) | Polypeptides therapeutiques, acides nucleiques codant ces polypeptides et methodes d'utilisation associees | |
WO2004029089A3 (fr) | Nouvelle cible de l’ angiogenese et utilisations | |
WO2001007479A3 (fr) | Matieres vivantes et methodes utiles pour le diagnostic ou le traitement de maladies | |
WO2003027231A3 (fr) | Polynucleotide codant pour une nouvelle proteine d'adaptation, pmn29, contenant le domaine d'homologie avec la pleckstrine et le domaine riche en proline | |
WO2007143578A3 (fr) | Protéines de perforine-2 | |
WO2002099116A3 (fr) | Polypeptides therapeutiques, acides nucleiques codant ces polypeptides et procedes d'utilisation | |
WO2009016231A3 (fr) | Compositions et procédés permettant de détecter des troubles liés à l'histamine | |
WO2004005487A3 (fr) | Polynucleotides codant une nouvelle proteine tubuline tyrosine ligase bgs42 specifique aux testicules |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
122 | Ep: pct application non-entry in european phase | ||
NENP | Non-entry into the national phase |
Ref country code: JP |
|
WWW | Wipo information: withdrawn in national office |
Country of ref document: JP |